How should I manage a middle‑aged to elderly man with transient acantholytic dermatosis (Grover’s disease) presenting with pruritic erythematous papules on the trunk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Grover's Disease (Transient Acantholytic Dermatosis)

First-Line Treatment: Topical Corticosteroids

Start with moderate- to high-potency topical corticosteroids applied 3-4 times daily for 2-4 weeks, as this achieves a 70% response rate and represents the most frequently employed and effective first-line therapy. 1

  • Apply emollients with high lipid content at least twice daily to all affected areas, as xerotic skin and impaired epidermal barrier function are fundamental to Grover's disease pathogenesis 2, 3, 4
  • Use hydrocortisone 2.5% or clobetasone butyrate for moderate cases, or clobetasol propionate for severe refractory lesions (though limit clobetasol to 2 consecutive weeks maximum and not exceeding 50g per week due to HPA axis suppression risk) 5, 6
  • The disease occurs more commonly in winter against a backdrop of xerotic epidermis with decreased sweat production, contrary to the traditional belief that heat and sweating cause it 4

Systemic Therapy for Inadequate Response

If topical corticosteroids fail after 2-4 weeks, escalate to systemic retinoids (86% response rate) or systemic corticosteroids (64% response rate) as second-line options. 1

  • Systemic retinoids demonstrate the highest response rate among all treatments and should be strongly considered for persistent cases 1
  • Oral corticosteroids can achieve rapid resolution, as demonstrated in recent case reports 7
  • The natural history shows spontaneous resolution in 42% of cases within one week to eight months, so treatment duration should be guided by clinical response 1

Symptomatic Management of Pruritus

Add non-sedating antihistamines for symptomatic relief of the characteristic intense pruritus:

  • Fexofenadine 180 mg daily or loratadine 10 mg daily are safe choices, particularly in the typical elderly male demographic 2, 3
  • Never use sedating antihistamines (diphenhydramine, hydroxyzine, chlorpheniramine) in elderly patients, as these increase fall risk, cause confusion, and may contribute to dementia 3, 5
  • Consider gabapentin 100-300 mg at bedtime, titrating to 900-3600 mg daily as tolerated, for refractory pruritus after 2-4 weeks of topical therapy 3, 5

Skin Care Modifications

  • Advise using mild soaps with neutral pH and warm (not hot) water, as the disease is associated with xerosis and impaired epidermal integrity 5, 4
  • Avoid excessive bathing, harsh soaps, and synthetic fabrics that may worsen the condition 2, 5
  • Keep nails short to minimize excoriation damage from scratching 5

Critical Diagnostic Considerations

The diagnosis requires both clinical and histopathologic confirmation:

  • Typical presentation: pruritic erythematous papules and vesicles on the trunk of middle-aged to elderly men (mean age 59 years, male-to-female ratio 3.95:1) 1, 8
  • Histopathology shows four different acantholytic patterns with suprabasal clefting, dyskeratotic cells (corps ronds and grains), and perivascular lymphocytic infiltrate 7, 8, 9
  • Consider screening for SARS-CoV-2 infection in patients presenting with new-onset Grover-like eruptions, as recent reports document this association 7
  • Examine for concurrent hematologic malignancies, as Grover's disease has been frequently associated with these conditions 8

Important Pitfalls to Avoid

  • Do not use crotamiton cream (ineffective, Level B recommendation against use) 3, 5
  • Avoid calamine lotion and topical capsaicin for this condition 2, 5
  • Do not dismiss the diagnosis based on atypical distribution—rare monolateral blaschkoid variants have been reported, particularly following occlusive environments from bandages 9
  • Recognize that the disease name "transient" is misleading, as many cases persist beyond the originally described temporary course 1, 8

Reassessment and Referral Criteria

  • Reassess after 2-4 weeks of topical corticosteroid therapy 5, 1
  • Refer to dermatology if no improvement after first-line therapy, if diagnostic uncertainty exists, or if skin biopsy is needed to confirm the diagnosis and exclude other acantholytic dermatoses like pemphigus or Darier's disease 2, 5, 9
  • Consider internal medicine evaluation for associated systemic conditions, particularly hematologic malignancies 8

References

Research

Clinical features and treatments of transient acantholytic dermatosis (Grover's disease): a systematic review.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020

Guideline

Differential Diagnosis and Management of Flat Pruritic Rashes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Elderly Patients with Pruritus and Sinus Congestion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Seasonal variation of transient acantholytic dyskeratosis (Grover's disease).

Journal of the American Academy of Dermatology, 2006

Guideline

Management of Stasis Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Grover disease (transient acantholytic dermatosis).

Archives of pathology & laboratory medicine, 2009

Research

Monolateral Grover's Disease with Blaschkoid Distribution.

Acta dermatovenerologica Croatica : ADC, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.